RVTY peer analysis
Revvity (RVTY) against its competitors: price, today's move, 1-year return and market value side by side.
RVTY and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| A Agilent | $174.76 | 1.73% | 19.07% | – |
| BIO Bio-Rad | $381.57 | 3.41% | 23.08% | $8.27B |
| CRL Charles River | $338.70 | 8.20% | 101.97% | $16.17B |
| DHR Danaher | $230.25 | 1.73% | 8.50% | $161.99B |
| MLAB Mesa Laboratories | $128.25 | 7.50% | 72.84% | $717.67M |
| MTD Mettler-Toledo | $1,722.15 | 2.57% | 19.62% | $34.51B |
| QGEN QIAGEN | $50.40 | -0.90% | 14.42% | $10.39B |
| TECH Bio-Techne | $72.78 | 0.17% | 21.42% | $11.43B |
| TMO Thermo Fisher | $694.76 | 2.63% | 22.39% | $257.42B |
| WAT Waters | $457.60 | 1.00% | 23.02% | $44.96B |
| RVTY Revvity | $155.11 | 2.84% | 67.56% | – |
- RVTY's peers: A (Agilent), BIO (Bio-Rad), CRL (Charles River), DHR (Danaher), MLAB (Mesa Laboratories), MTD (Mettler-Toledo), QGEN (QIAGEN), TECH (Bio-Techne).
Updated 2026-11-07 11:54 UTC